Refers to: Paul Enck. Not more, but less studies are warranted—If you take your meta-analysis seriously

dc.contributor.authorShin, Andrea S.
dc.contributor.authorImperiale, Thomas F.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2020-03-02T19:02:27Z
dc.date.available2020-03-02T19:02:27Z
dc.date.issued2019-01
dc.description.abstractThis submission is in reply to a letter by Dr. Paul Enck regarding our recent conclusions regarding the clinical efficacy of patented probiotic, VSL#3, in Irritable Bowel Syndrome.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationShin, A. S., & Imperiale, T. F. (2019). Refers to: Paul Enck. Not more, but less studies are warranted—If you take your meta‐analysis seriously. Neurogastroenterology & Motility, 31(1), e13490. 10.1111/nmo.13490en_US
dc.identifier.issn1365-2982en_US
dc.identifier.urihttps://hdl.handle.net/1805/22201
dc.language.isoen_USen_US
dc.publisherWileyen_US
dc.relation.isversionof10.1111/nmo.13490en_US
dc.relation.journalNeurogastroenterology and Motilityen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectMeta‐analysisen_US
dc.subjectIrritable bowel syndromeen_US
dc.subjectAbdominal pain scoresen_US
dc.subjectVSL#3en_US
dc.titleRefers to: Paul Enck. Not more, but less studies are warranted—If you take your meta-analysis seriouslyen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-989953.pdf
Size:
31.17 KB
Format:
Adobe Portable Document Format
Description:
Author's Manuscript
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: